ZA9670B - Composition and methods for transdermal delivery of acid-lability drugs - Google Patents

Composition and methods for transdermal delivery of acid-lability drugs

Info

Publication number
ZA9670B
ZA9670B ZA9670A ZA9670A ZA9670B ZA 9670 B ZA9670 B ZA 9670B ZA 9670 A ZA9670 A ZA 9670A ZA 9670 A ZA9670 A ZA 9670A ZA 9670 B ZA9670 B ZA 9670B
Authority
ZA
South Africa
Prior art keywords
lability
drugs
acid
composition
methods
Prior art date
Application number
ZA9670A
Other languages
English (en)
Inventor
Chensheng Li
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of ZA9670B publication Critical patent/ZA9670B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9670A 1995-01-06 1996-01-05 Composition and methods for transdermal delivery of acid-lability drugs ZA9670B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36975695A 1995-01-06 1995-01-06

Publications (1)

Publication Number Publication Date
ZA9670B true ZA9670B (en) 1996-07-18

Family

ID=23456790

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9670A ZA9670B (en) 1995-01-06 1996-01-05 Composition and methods for transdermal delivery of acid-lability drugs

Country Status (16)

Country Link
EP (1) EP0801561B1 (fr)
JP (1) JP4081139B2 (fr)
KR (1) KR100543351B1 (fr)
AR (1) AR002701A1 (fr)
AT (1) ATE292457T1 (fr)
AU (1) AU718530B2 (fr)
CA (1) CA2209669C (fr)
DE (1) DE69634559T2 (fr)
DK (1) DK0801561T3 (fr)
ES (1) ES2239767T3 (fr)
IL (1) IL116539A (fr)
NZ (1) NZ301153A (fr)
PT (1) PT801561E (fr)
TW (1) TW438598B (fr)
WO (1) WO1996020699A1 (fr)
ZA (1) ZA9670B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
EP1021204B1 (fr) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Compositions bioadhesives et methodes d'administration locale d'agents actifs
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
BRPI0210074B1 (pt) * 2001-05-31 2017-05-30 Hisamitsu Pharmaceutical Co emplastro de anti-inflamatórios não esteroidais percutaneamente absorvível, contendo sais de amônio, promotores de permeação e/ou agentes de solubilização em uma camada de substrato adesivo
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
FR2905601A1 (fr) * 2006-09-11 2008-03-14 Innoderm Sarl Utilisation de derives oleiques comme methode et composition favorisant la penetration cutanee des actifs contenus dans les compositions cosmetiques, pharmaceutiques ou dermatologiques.
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
KR100963162B1 (ko) * 2008-12-15 2010-06-15 김유근 5-아미노레불린산의 안정화 방법
US10213421B2 (en) 2012-04-04 2019-02-26 Alkahest, Inc. Pharmaceutical formulations comprising CCR3 antagonists
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
CN109503692A (zh) * 2018-12-05 2019-03-22 华中药业股份有限公司 一种雄甾-17α-甲基-17β-羟基-3-酮的合成方法
US20220160697A1 (en) 2019-03-19 2022-05-26 Nobelpharma Co., Ltd. Pharmaceutical composition having excellent drug absorption into the living body and excellent chemical stability

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685895T2 (de) * 1985-02-25 1992-12-24 Univ Rutgers Dosierungssystem fuer transdermale absorption von arzneimittelwirkstoffen.
AU601528B2 (en) * 1986-12-22 1990-09-13 Ortho-Mcneil Pharmaceutical, Inc. Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
CN1021196C (zh) * 1986-12-29 1993-06-16 新泽西州州立大学(鲁杰斯) 透皮雌激素/孕激素药剂单元、系统及方法
US4994267A (en) * 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
EP0394429B1 (fr) * 1988-10-27 1996-01-10 Schering Aktiengesellschaft Preparation pour application transcutanee renfermant du gestodene
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren

Also Published As

Publication number Publication date
CA2209669C (fr) 2007-03-27
DE69634559D1 (de) 2005-05-12
JPH10512245A (ja) 1998-11-24
KR100543351B1 (ko) 2006-04-06
EP0801561B1 (fr) 2005-04-06
AR002701A1 (es) 1998-04-29
EP0801561A2 (fr) 1997-10-22
IL116539A0 (en) 1996-03-31
JP4081139B2 (ja) 2008-04-23
WO1996020699A1 (fr) 1996-07-11
DE69634559T2 (de) 2006-02-16
AU4650596A (en) 1996-07-24
ATE292457T1 (de) 2005-04-15
NZ301153A (en) 1999-11-29
IL116539A (en) 2002-02-10
DK0801561T3 (da) 2005-08-08
MX9705070A (es) 1998-07-31
AU718530B2 (en) 2000-04-13
CA2209669A1 (fr) 1996-07-11
KR19980701233A (ko) 1998-05-15
TW438598B (en) 2001-06-07
ES2239767T3 (es) 2005-10-01
PT801561E (pt) 2005-07-29

Similar Documents

Publication Publication Date Title
IL127189A0 (en) Compositions methods and devices for the transdermal delivery of drugs
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
AU1970495A (en) Drug delivery device and method of construction
AU2259692A (en) Composition and method for transdermal delivery of diclofenac
AU7601998A (en) Composition and methods for transdermal delivery of acid labile drugs
EP0858334A4 (fr) Composition pharmaceutique analgesique a liberation immediate et a liberation lente
ZA968907B (en) Compositions and methods for buccal delivery of pharmaceutical agents
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
AU7236596A (en) Transdermal administration of ropinirole and analogs thereof
AU4534593A (en) Compositions and methods for enhanced drug delivery
AU6042696A (en) Drug delivery catheters and methods of use
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
AU6257896A (en) Device for transdermal electrotransport delivery of fentanyl and sufentanil
HUP9902105A3 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
EP0776215A4 (fr) Dispositif d'administration de substances et ses modes d'utilisation
IL117728A0 (en) Pharmaceutical compositions for transdermal administration
PL326078A1 (en) Transcytotic carriers and enhancers for delivery of drugs
EP0572932A3 (en) Method and implant device for long term delivery of drugs
AU4981896A (en) Liposome composition and method for administering liposome-loadable drugs
ZA9670B (en) Composition and methods for transdermal delivery of acid-lability drugs
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
GB9725546D0 (en) Devic efor transdermal electransport delivery of fentanyl and sufentanil
AU1429697A (en) Systems and methods for the transdermal administration of androgenic agents
AU5155198A (en) Method and composition for transdermal administration of pharmacologic agent
AU2559995A (en) Transdermal delivery of anti-epileptic drugs